Publication | Closed Access

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model

Neurodegenerative DiseasesAlzheimer's DiseaseG Protein-coupled ReceptorMedicinePhysiologyNeuroscienceStz Rat ModelAlzheimer IcvAging-associated DiseaseCognitive DeclineInsulin Signaling